Sponsor
Cedars-Sinai Medical Center
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT05347342
To improve upon the non-invasive detection of bladder cancer by further validating a multiplex ELISA assay directed at a bladder cancer-associated diagnostic signature in voided urine samples of patients with a high risk of developing bladder cancer.
Condition
Bladder Cancer
Investigators
Hideki Furuya, Charles J Rosser, MD, MBA, Greg Gin, MD